
Late-life semaglutide treatment in mice: a research article examining whether a diabetes drug can mimic calorie restriction to slow ageing and preserve function. Open to learn what kind of experimental and comparative study the paper presents and why it matters for ageing research.
Key Takeaways
- Use of GLP-1 medicines has revealed pleiotropic beneficial effects beyond glucose and weight control 2
- Attenuated hallmarks of ageing and modulated nutrient sensors and conserved genetic regulators of ageing
- In a longitudinal study in direct comparison to matched calorie restriction
